Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
31.98
+0.12 (0.38%)
At close: Jun 27, 2025, 4:00 PM
32.00
+0.02 (0.06%)
After-hours: Jun 27, 2025, 7:53 PM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $1.84 billion as of June 27, 2025. Its market cap has increased by 8.91% in one year.
Market Cap
1.84B
Enterprise Value
1.51B
1-Year Change
8.91%
Ranking
Category
Stock Price
$31.98
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.84B, an increase of 298.33%. That is a compound annual growth rate of 32.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 1.84B | -6.42% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | 2.06B | 346.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 716.12B |
| Johnson & Johnson | 366.16B |
| AbbVie | 329.91B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 276.45B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.93B |
| AstraZeneca | 215.99B |